IPO - Profile


Our purpose is to enable and accelerate the field of proteomics by providing a platform of products and services, developed with key opinion leaders (KOLs), that are deployed across major biopharmaceutical companies and leading clinical and academic institutions, to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. Since our inception, we have served a customer base of approximately 630 customer accounts in over 40 countries worldwide. We support 30 of the world’s largest 40 biopharmaceutical companies by 2019 revenue, including all More

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$20.00 17,700,000 Positive High 4.39%

Offering Team

  • Legal counsel
  • Goodwin Procter LLP
  • Auditors
  • PricewaterhouseCoopers Accountants N.V

Deal Highlights

Deal Tracker

IPO Dates

Filing 24 Mar, 2021

Offer 25 Mar, 2021

Look Ahead

Lock Up Expiry Sep 25, 2021

IPO Terms

Offer Price $20.00
Offer Size 17M

Market Sentiments

Stock Price